MedPath

Reconstruction of Localized Alveolar Ridge Defects

Phase 4
Recruiting
Conditions
Partial-edentulism
Interventions
Procedure: Full-thickness group
Procedure: Split-thickness group
Registration Number
NCT05538715
Lead Sponsor
Semmelweis University
Brief Summary

The aim of the present prospective randomized controlled study is to compare the clinical, radiological, micro-circulation, and histology of a novel, semi-thick, and conventional full-thickness mucoperiosteal flap technique during horizontal alveolar ridge augmentation.

Detailed Description

The aim of our study was to compare the clinical, radiological, circulatory, and histological studies of a novel, split-thickness and conventional full-thickness mucoperiosteal flap technique during horizontal alveolar ridge augmentation surgeries. Flap formation was performed in the test group using the novel split-thickness surgical technique, and in the control group using the full-thickness mucoperostatial surgical technique. The novel split-thickness flap technique to be studied results in a predictable, closed healing based on our preliminary results, thus ensuring the conditions for successful augmentation. We primarily want to investigate what hard and soft tissue changes result from ridge augmentation with a novel split-thickness flap technique after 6 months, compared to a surgical technique based on full thick flap formation accepted as a standard procedure in the literature. Our secondary examination methods: examination of early wound healing and micro-circulation after augmentation interventions by LSCI method; histological evaluation at prosthetically designed implant positions.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria
  • at least one edentulous maxillary/mandibulary premolar or molar site with horizontal bone loss
  • full- mouth plaque and bleeding scores (FMPS and FMBS) <20%
  • good patient compliance (including willingness to participate in the follow-up procedures) signed informed consent-
Exclusion Criteria
  • Active infectious diseases (HBV, HCV, HIV, TB, SARS CoV-2, etc.)
  • Current chemotherapy or radiotherapy
  • Radiation treatment of the former head and neck region (not older than 2 years)
  • Untreated insulin-dependent diabetes mellitus
  • Clinically significant osteoporosis or other systemic disease affecting bone metabolism
  • Clinically significant circulatory disorders such as decompensated cardiac failure
  • Haemodynamically significant heart failure or myocardial infarction within the last 3 months
  • Clinically significant coagulation disorder
  • Current or previous systemic corticosteroid therapy (not older than 2 months)
  • Current or previous systemic bisphosphonate therapy
  • Pregnant or breastfeeding mothers
  • Smoking
  • Drug addiction, alcoholism

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Full-thickness groupFull-thickness groupFollowing randomization, horizontal guided bone regeneration utilizing Bio-Oss (Geistlich, Wolhusen, Switzerland) and autogenous bone in combination with Bio-Gide membrane (Geistlich, Wolhusen, Switzerland). Surgery is performed with a full-thickness flap design in the posterior maxilla or mandible in partially edentolous patients.
Split-thickness groupSplit-thickness groupFollowing randomization, horizontal guided bone regeneration utilizing Bio-Oss (Geistlich, Wolhusen, Switzerland) and autogenous bone in combination with Bio-Gide membrane (Geistlich, Wolhusen, Switzerland). Surgery is performed with a split-thickness flap design in the posterior maxilla or mandible in partially edentolous patients.
Primary Outcome Measures
NameTimeMethod
Orovestibular ridge width6 months postoperatively

On prealigned pre- and postoperative CBCT cross-sections, linear measurements were taken parallel to a reference base to determine the orovestibular width of the surgical area.

Dimensional change of keratinized Gingiva6 months postoperatively

Pre-and postoperatively a surface scan is performed using a Planmeca Emerald intraroral scanner. The superimposition of the measurements was used to evaluate the soft tissue changes associated with the treatments in 3 dimension.

Secondary Outcome Measures
NameTimeMethod
Histomorphometrical analysisFollowing reentry 6 months after augmentation

Percentage of newly formed bone, bone substitute and connective tissue

Gingival blood flow measurement at the early wound healing phasePre-operative and 1, 3, 5, 7, 10, 14, 21, 28 days and 2, 3, 4, 5 and 6 months after surgeries.

Investigation of pre- and postoperative gingival blood flow using Laser Speckle Contrast Imager.

Trial Locations

Locations (1)

Semmelweis University Department of Periodontology

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath